With so many central banks meeting this week, Saxo's Kay Van-Petersen discusses the currency...

Biotechnology stocks have fallen significantly since their July peak. But because of the noise...

The massive rally in the biotechnology sector is not over according to Serge Berger, also known...

Expect them to be disappointing. That's what Saxo's Peter Garnry predicts ahead of...

Serge Berger, who is also known as The Steady Trader, believes the NASDAQ Biotechnology ETF...